secwatch / observer
8-K filed May 14, 2024, 7:59 PM ET ticker OSRH CIK 0001840425
other material confidence high sentiment neutral materiality 0.70

OSR Holdings, Inc. (OSRH): debt financing — Bellevue Life Sciences SPAC extends business combination deadline to Nov 14, 2024; 1.58M shares redeemed

OSR Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

OSR Holdings, Inc. incurred loan of $140,000 with Bellevue Global Life Sciences Investors LLC at not interest bearing maturing the earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial business combination.

Instrument
loan
Principal
$140,000
Counterparty
Bellevue Global Life Sciences Investors LLC
Rate
not interest bearing
Maturity
the earlier of: (i) December 31, 2024 or (ii) the date on which the Company consummates an initial business combination
Event
incurrence
Exact text from the filing
On May 14, 2024, Bellevue Life Sciences Acquisition Corp. (the " Company ") issued an unsecured promissory note (the " Promissory Note ") in the principal amount of $140,000 to Bellevue Global Life Sciences Investors LLC (" BGLSI "), the sponsor of the Company.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

OSR Holdings, Inc.: The Company amended its charter to extend the business combination deadline from May 14, 2024 to November 14, 2024 (effective 2024-05-14).

Change
charter amendment
Effective
2024-05-14
Exact text from the filing
On May 14, 2024, the Company held a special meeting of its stockholders (the “ Special Meeting ”). At the Special Meeting, the Company’s stockholders approved a proposal (the “ Extension Amendment Proposal ”) to amend to the Company’s Amended and Restated Certificate of Incorporation (the “ Charter ”) to allow the Company to extend the date by which the Company must consummate a business combination from May 14, 2024, to November 14, 2024. The Certificate of Amendment to the Charter (the “ Charter Amendment ”) was filed with the Delaware Secretary of State and has an effective date of May 14, 2024.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

OSR Holdings, Inc. shareholders approved approval of adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or to establish quorum at the 2024-05-14 meeting.

Outcome
passed
Meeting
2024-05-14
Exact text from the filing
Proposal 2 - Adjournment Proposal The stockholders approved the proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or to establish quorum by the votes set forth in the table below: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,831,081 507,414 — —
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

OSR Holdings, Inc. shareholders approved amendment to the Charter to allow the Company to extend the date by which the Company must consummate a business combination from May 14, 2024 to November 14, 2024 at the 2024-05-14 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2024-05-14
Exact text from the filing
Proposal 1 - Extension Amendment Proposal The stockholders approved the proposal to amend the Charter to allow the Company to extend the date by which the Company must consummate a business combination from May 14, 2024 to November 14, 2024 by the votes set forth in the table below: FOR AGAINST ABSTAIN BROKER NON-VOTES 3,835,399 503,096 — —
View on SEC.gov

310 debt financings filed in the last 30 days. Browse all debt financings →

OSR Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-138268
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.